BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34584067)

  • 1. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
    Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
    Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway.
    Yu C; Chen H; Zhao Y; Zhang Y
    Med Sci Monit; 2021 Dec; 27():e931970. PubMed ID: 34911926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.
    Quan M; Cui J; Xia T; Jia Z; Xie D; Wei D; Huang S; Huang Q; Zheng S; Xie K
    Cancer Res; 2015 Nov; 75(22):4778-4789. PubMed ID: 26483206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.
    Shen J; Xie M; Xu Y; Qian Q; Qiu T; Shi W; Ren D; Ji J; Huang J
    Biochem Biophys Res Commun; 2023 Jan; 638():184-191. PubMed ID: 36462492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
    Li Z; Huang X; Hu W; Lu H
    Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
    Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
    Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
    Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
    Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
    Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
    Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
    Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer.
    Tang Q; Liu C; Zhang S; He L; Liu Y; Wang J; Zhao X; Li X
    Neoplasia; 2023 Feb; 36():100863. PubMed ID: 36528911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1-regulated Wnt/β-catenin pathway.
    Chen Y; Yang Y; Wang N; Liu R; Wu Q; Pei H; Li W
    J Cell Mol Med; 2024 Feb; 28(3):e18072. PubMed ID: 38063438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.